FF:0000350

outline

• id: FF:0000350
• name: experimentally modified sample
• namespace: FANTOM5

• created_by: tmeehan
• creation_date: 29 April 2011 10:41:03
• CAGEd oPOSSUM: NA

Ontology association

Parents

is_a:	FF:0000001(sample)

Children

is a:

FF:0000408 (cellular fractionation sample),FF:0000410 (human Lymphatic Endothelial cells 0min after VEGFC treatment sample),FF:0000411 (human Lymphatic Endothelial cells 15min after VEGFC treatment sample),FF:0000412 (human Lymphatic Endothelial cells 30min after VEGFC treatment sample),FF:0000413 (human Lymphatic Endothelial cells 45min after VEGFC treatment sample),FF:0000414 (human Lymphatic Endothelial cells 1hr after VEGFC treatment sample),FF:0000415 (human Lymphatic Endothelial cells 80min after VEGFC treatment sample),FF:0000416 (human Lymphatic Endothelial cells 100min after VEGFC treatment sample),FF:0000417 (human Lymphatic Endothelial cells 2h after VEGFC treatment sample),FF:0000418 (human Lymphatic Endothelial cells 2.5h after VEGFC treatment sample),FF:0000419 (human Lymphatic Endothelial cells 3h after VEGFC treatment sample),FF:0000420 (human Lymphatic Endothelial cells 3.5h after VEGFC treatment sample),FF:0000421 (human Lymphatic Endothelial cells 4h after VEGFC treatment sample),FF:0000422 (human Lymphatic Endothelial cells 5h after VEGFC treatment sample),FF:0000423 (human Lymphatic Endothelial cells 6h after VEGFC treatment sample),FF:0000424 (human Lymphatic Endothelial cells 7h after VEGFC treatment sample),FF:0000425 (human Lymphatic Endothelial cells 8h after VEGFC treatment sample),FF:0000426 (human MCF7 breast cancer cell line 0min after EGF1 treatment sample),FF:0000427 (human MCF7 breast cancer cell line 15min after EGF1 treatment sample),FF:0000428 (human MCF7 breast cancer cell line 30min after EGF1 treatment sample),FF:0000429 (human MCF7 breast cancer cell line 45min after EGF1 treatment sample),FF:0000430 (human MCF7 breast cancer cell line 1hr after EGF1 treatment sample),FF:0000431 (human MCF7 breast cancer cell line 80min after EGF1 treatment sample),FF:0000432 (human MCF7 breast cancer cell line 100min after EGF1 treatment sample),FF:0000433 (human MCF7 breast cancer cell line 2h after EGF1 treatment sample),FF:0000434 (human MCF7 breast cancer cell line 2.5h after EGF1 treatment sample),FF:0000435 (human MCF7 breast cancer cell line 3h after EGF1 treatment sample),FF:0000436 (human MCF7 breast cancer cell line 3.5h after EGF1 treatment sample),FF:0000437 (human MCF7 breast cancer cell line 4h after EGF1 treatment sample),FF:0000438 (human MCF7 breast cancer cell line 5h after EGF1 treatment sample),FF:0000439 (human MCF7 breast cancer cell line 6h after EGF1 treatment sample),FF:0000440 (human MCF7 breast cancer cell line 7h after EGF1 treatment sample),FF:0000441 (human MCF7 breast cancer cell line 8h after EGF1 treatment sample),FF:0000442 (MCF7 breast cancer cell line 0min after HRG treatment),FF:0000443 (human MCF7 breast cancer cell line 15min after HRG treatment sample),FF:0000444 (human MCF7 breast cancer cell line 30min after HRG treatment sample),FF:0000445 (human MCF7 breast cancer cell line 45min after HRG treatment sample),FF:0000446 (human MCF7 breast cancer cell line 1hr after HRG treatment sample),FF:0000447 (human MCF7 breast cancer cell line 80min after HRG treatment sample),FF:0000448 (human MCF7 breast cancer cell line 100min after HRG treatment sample),FF:0000449 (human MCF7 breast cancer cell line 2h after HRG treatment sample),FF:0000450 (human MCF7 breast cancer cell line 2.5h after HRG treatment sample),FF:0000451 (human MCF7 breast cancer cell line 3h after HRG treatment sample),FF:0000452 (human MCF7 breast cancer cell line 3.5h after HRG treatment sample),FF:0000453 (human MCF7 breast cancer cell line 4h after HRG treatment sample),FF:0000454 (human MCF7 breast cancer cell line 5h after HRG treatment sample),FF:0000455 (human MCF7 breast cancer cell line 6h after HRG treatment sample),FF:0000456 (human MCF7 breast cancer cell line 7h after HRG treatment sample),FF:0000457 (human MCF7 breast cancer cell line 8h after HRG treatment sample),FF:0000458 (mouse ST2 Mesenchymal stem cells, cells 15 min after adipogenic induction sample)... further results

FF Samples

Human

• 11843-124H7 (serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1)
• 12680-135B7
• 12681-135B8
• 12682-135B9
• 12683-135C1
• 12684-135C2
• 12685-135C3
• 12686-135C4
• 12687-135C5
• 12688-135C6
• 12689-135C7
• 12690-135C8
• 12691-135C9
• 12692-135D1
• 12693-135D2
• 12694-135D3
• 12695-135D4
• 12696-135D5
• 12697-135D6 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17))
• 12778-136D6
• 12779-136D7
• 12780-136D8
• 12781-136D9
• 12782-136E1
• 12783-136E2
• 12784-136E3
• 12785-136E4
• 12786-136E5
• 12787-136E6
• 12788-136E7
• 12789-136E8
• 12790-136E9
• 12791-136F1
• 12792-136F2
• 12793-136F3
• 12794-136F4
• 12795-136F5 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17))
• 12876-137F5
• 12877-137F6
• 12878-137F7
• 12879-137F8
• 12880-137F9
• 12881-137G1
• 12882-137G2
• 12883-137G3
• 12884-137G4
• 12885-137G5
• 12886-137G6
• 12887-137G7
• 12888-137G8

... further results